⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S1 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression

Jordan L. Kohlmeyer Joshua J. Lingo Courtney A. Kaemmer Amanda Scherer Akshaya Warrier Ellen Voigt Juan A. Raygoza Garay Gavin R. McGivney Qierra R. Brockman Amy Tang Ana Calizo Kai Pollard Xiaochun Zhang Angela C. Hirbe Christine A. Pratilas Mariah Leidinger Patrick Breheny Michael S. Chimenti Jessica C. Sieren Varun Monga Munir R. Tanas David K. Meyerholz Benjamin W. Darbro Rebecca D. Dodd Dawn E. Quelle

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S1. Combination therapy co-targeting CDK4/6 and MEK acts synergistically against MPNST cells in vitro

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kohlmeyer et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db64358752270d https://doi.org/10.1158/1078-0432.27032923

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
2Supplementary Figure S8 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
3Supplementary Figure S8 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
4Supplementary Figure S6 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
5Supplementary Figure S6 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024

Supplementary Figure S2 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
Supplementary Figure S2 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
Supplementary Figure S3 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024